Modulation of the Immune System in Inflammatory Diseases and Hidradenitis Suppurativa
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 211
Special Issue Editors
2. Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany
Interests: dermatooncology; hidradenitis suppurativa; inflammation; melanoma; endocrinology; skin cancer; surgery; psoriasis; skin
Special Issues, Collections and Topics in MDPI journals
2. Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany
Interests: hidradenitis suppurativa; inflammation; hormones; Merkel cell carcinoma; melanoma; endocrinology; skin cancer; obesity
Special Issue Information
Dear Colleagues,
In inflammatory diseases, a disbalance of the immune system plays a decisive role. An increasing number of drugs, biologics, and vaccines are being developed to modulate the immune system. Many immunomodulators suppress proinflammatory cytokines and stabilise inflammatory diseases.
For this Special Issue, entitled “Modulation of the Immune System in Inflammatory Diseases and Hidradenitis Suppurativa”, review articles, original articles, and larger case series from various specialities of rheumatology, dermatology, neurology, gastroenterology, endocrinology, virology, pharmacology, and oncology are welcome. Topics will include, but are not limited to, the following areas:
- Inflammatory diseases and potential immune system modulators;
- Newly discovered targets for drugs or vaccines in inflammatory diseases;
- New insights into the pathogenesis of inflammatory diseases;
- Potential adverse effects of immunomodulators or treatment response.
You may choose our Joint Special Issue in JCM.
Prof. Dr. Falk Georges Bechara
Guest Editor
Dr. Nessr Abu Rached
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- hidradenitis suppurativa
- psoriasis
- HS
- acne inversa
- skin diseases
- therapy
- inflammatory diseases
- inflammatory
- immune system
- vaccines
- signalling pathways
- multiple sclerosis
- myositis
- neuritis
- Lyme disease
- Crohn's disease
- morbus Crohn
- ulcerative colitis
- axial spondyloarthritis
- rheumatoid arthritis
- thyroiditis
